Aspen settled its mRNA manufacturing dispute, with the counterparty agreeing to pay €25m (≈R500m). The settlement provides a modest cash inflow and improved clarity on earnings.
Click here to read the SENS
Aspen settled its mRNA manufacturing dispute, with the counterparty agreeing to pay €25m (≈R500m). The settlement provides a modest cash inflow and improved clarity on earnings.
Click here to read the SENS